OncoMatch/Clinical Trials/NCT04191460
Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer
Is NCT04191460 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies cRGD-ZW800-1. for squamous cell carcinoma of the head and neck.
Treatment: cRGD-ZW800-1. — This is a two-staged clinical trial to investigate the feasibility of intraoperative Fluorescence Imaging (FLI) to adequately assess tumor margins in patients with oral cancer using cRGD-ZW800-1.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Head and Neck Squamous Cell Carcinoma
Prior therapy
Cannot have received: surgery
Previous surgery ... to the oral cavity
Cannot have received: chemotherapy
Previous ... chemotherapy ... to the oral cavity
Cannot have received: radiotherapy
Previous ... radiotherapy to the oral cavity
Lab requirements
Kidney function
egfr >= 60
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT04191460 currently recruiting?
Yes, this trial is currently recruiting patients.
Can patients have received prior systemic therapy?
No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages